Anlon Healthcare IPO Last Date, Price, Prospectus PDF

Anlon Healthcare has released IPO and all details of IPO such as last date to apply, price, prospectus PDF and all other details are given below.

Anlon Healthcare IPO Details

IPO Open Date	August 26, 2025
IPO Close Date	August 29, 2025
Face Value	₹10 Per Equity Share
IPO Price Band	₹86 to ₹91 Per Share
Issue Size	Approx ₹121.03 Crores
Fresh Issue	Approx ₹121.03 Crores
Lot Size	164 Shares
Issue Type	Book Build IPO
IPO Listing	BSE & NSE
Retail Quota	Not more than 10%
QIB Quota	Not more than 75%
NII Quota	Not more than 15%
Download Prospectus PDF	Click Here

Anlon Healthcare IPO Dates and Schedule

IPO Open Date	August 26, 2025
IPO Close Date	August 29, 2025
Basis of Allotment	September 1, 2025
Refunds	September 2, 2025
Credit to Demat Account	September 2, 2025
IPO Listing Date	September 3, 2025

About Anlon Healthcare IPO

Anlon Healthcare Limited, established in 2013, is a growing chemical manufacturing company that mainly produces two types of products. First, it makes high-purity pharmaceutical intermediates, which are raw materials used for creating active pharmaceutical ingredients (APIs). Second, it manufactures APIs themselves, which are essential components used in making medicines such as tablets, capsules, ointments, syrups, as well as in nutraceuticals, personal care items, and animal health products. The company’s product portfolio includes pharmaceutical intermediates, APIs, nutraceutical APIs, and ingredients for personal care and veterinary products.

Anlon Healthcare is also one of the few Indian companies that produce loxoprofen sodium dihydrate, an API widely used to treat severe pain caused by conditions like arthritis, back pain, frozen shoulder, toothache, or post-surgery recovery. As of January 31, 2025, the company had 105 employees (excluding trainees) and 8 contract workers. At the time of filing its DRHP, the company had 65 commercial products, 28 products in the pilot stage, and 49 products undergoing laboratory testing.